Business Context and Reporting Period
This Form 8-K was filed by SeaStar Medical Holding Corp on August 22, 2023. The filing serves as a Regulation FD disclosure to distribute a business update presentation and conference call materials to the public. The company is incorporated in Delaware and trades on The Nasdaq Stock Market under the symbols ICU (Common Stock) and ICUCW (Warrants).
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural filing to announce the availability of a presentation rather than a financial report containing audited or unaudited financial statements.
Material Changes
No material changes to financial performance or operations are detailed within the text of this filing. The primary event reported is the release of a presentation used during a business update conference call held on August 22, 2023.
Guidance, Outlook, and Risks
Management commentary, specific guidance, outlook, risks, and contingencies are contained within the attached presentation (Exhibit 99.1) and the recorded webcast, which are referenced but not included in the text of this filing. The filing notes that the company is an emerging growth company.
Key Facts for Investor Verification
- Verify the content of the business update presentation (Exhibit 99.1) and the recorded webcast available on the company's investor relations website for actual financial data and strategic updates.
- Confirm the trading status of the Common Stock (ICU) and Warrants (ICUCW) on The Nasdaq Stock Market.
- Note that the filing was signed by Eric Schlorff, Chief Executive Officer, on August 24, 2023.